- Home
- WKSP vs COCP Comparison
WKSP vs COCP Comparison
Compare WKSP & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKSP
- COCP
- Stock Information
- Founded
- WKSP 2003
- COCP 2006
- Country
- WKSP United States
- COCP United States
- Employees
- WKSP N/A
- COCP N/A
- Industry
- WKSP Auto Parts:O.E.M.
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- WKSP Consumer Discretionary
- COCP Health Care
- Exchange
- WKSP Nasdaq
- COCP Nasdaq
- Market Cap
- WKSP 14.7M
- COCP 15.7M
- IPO Year
- WKSP N/A
- COCP N/A
- Fundamental
- Price
- WKSP $2.97
- COCP $1.55
- Analyst Decision
- WKSP Strong Buy
- COCP Strong Buy
- Analyst Count
- WKSP 3
- COCP 1
- Target Price
- WKSP $12.83
- COCP $7.00
- AVG Volume (30 Days)
- WKSP 243.1K
- COCP 25.8K
- Earning Date
- WKSP 08-12-2025
- COCP 05-15-2025
- Dividend Yield
- WKSP N/A
- COCP N/A
- EPS Growth
- WKSP N/A
- COCP N/A
- EPS
- WKSP N/A
- COCP N/A
- Revenue
- WKSP $10,211,747.00
- COCP N/A
- Revenue This Year
- WKSP $159.92
- COCP N/A
- Revenue Next Year
- WKSP $68.25
- COCP N/A
- P/E Ratio
- WKSP N/A
- COCP N/A
- Revenue Growth
- WKSP 407.96
- COCP N/A
- 52 Week Low
- WKSP $2.44
- COCP $1.12
- 52 Week High
- WKSP $12.00
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- WKSP 46.98
- COCP 49.70
- Support Level
- WKSP $2.95
- COCP $1.45
- Resistance Level
- WKSP $3.59
- COCP $1.62
- Average True Range (ATR)
- WKSP 0.32
- COCP 0.13
- MACD
- WKSP 0.01
- COCP -0.01
- Stochastic Oscillator
- WKSP 28.81
- COCP 27.78
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).